Nogawa S
Department of Neurology, School of Medicine, Keio University, Tokyo, Japan.
Keio J Med. 1995 Mar;44(1):19-29. doi: 10.2302/kjm.44.19.
The present study was designed to determine the effects of intravenous infusion of L-arginine (ARG), an endogenous precursor of nitric oxide (NO), on the cerebral circulation in the rat. Systemic arterial blood pressure (ABP) was continuously recorded, and local cerebral blood flow (LCBF) was measured by the iodo[14C]antipyrine method at a point of time as follows: In Saline group (n = 12); at 3 min after an intravenous injection of saline. In NG-monomethyl-L-arginine (L-NMMA) group (n = 7); at 3 min after an injection of L-NMMA (30 mg/kg/30 sec). In L-NMMA+L-ARG group (n = 7); at 3 min after an infusion of L-ARG free base (300 mg/kg/1 min) 3 min after prior injection of L-NMMA (30 mg/kg/30 sec). In L-ARG-1 group (n = 7); during an infusion of L-ARG free base (300 mg/kg/1 min). In L-ARG-2 group (n = 8); at 3 min after an administration of L-ARG free base (300 mg/kg/1 min). In D-ARG group (n = 5); at 3 min after an infusion of D-ARG free base (300 mg/kg/1 min). (1) The diffuse reduction in LCBF and increase in ABP induced by L-NMMA were almost completely reversed by excess L-ARG. (2) During the administration of L-ARG, a sustained decrease in ABP was observed, but LCBF revealed no significant change. (3) At 3 min after the infusion of L-ARG, LCBF was significantly decreased in several regions, while ABP recovered. (4) The infusion of D-ARG also induced a transient decrease in ABP, but did not alter LCBF. The effect of L-ARG on ABP may not be entirely due to an increase in substrate availability for NO synthase, since the D-enantiomer also had some vasodilatory property. Regarding the therapeutic application of L-ARG, further investigations on its actions should be performed under various conditions.
本研究旨在确定静脉输注一氧化氮(NO)的内源性前体L-精氨酸(ARG)对大鼠脑循环的影响。连续记录全身动脉血压(ABP),并在以下时间点通过碘[14C]安替比林法测量局部脑血流量(LCBF):生理盐水组(n = 12),静脉注射生理盐水后3分钟;N-甲基-L-精氨酸(L-NMMA)组(n = 7),注射L-NMMA(30 mg/kg/30秒)后3分钟;L-NMMA + L-ARG组(n = 7),在注射L-NMMA(30 mg/kg/30秒)3分钟后输注L-精氨酸游离碱(300 mg/kg/1分钟)3分钟后3分钟;L-ARG-1组(n = 7),输注L-精氨酸游离碱(300 mg/kg/1分钟)期间;L-ARG-2组(n = 8),给予L-精氨酸游离碱(300 mg/kg/1分钟)后3分钟;D-ARG组(n = 5),输注D-精氨酸游离碱(300 mg/kg/1分钟)后3分钟。(1)过量的L-ARG几乎完全逆转了L-NMMA引起的LCBF弥漫性降低和ABP升高。(2)在给予L-ARG期间,观察到ABP持续下降,但LCBF无显著变化。(3)输注L-ARG后3分钟,几个区域的LCBF显著降低,而ABP恢复。(4)输注D-ARG也引起ABP短暂下降,但未改变LCBF。L-ARG对ABP的作用可能不完全归因于NO合酶底物可用性的增加,因为D-对映体也具有一些血管舒张特性。关于L-ARG的治疗应用,应在各种条件下对其作用进行进一步研究。